Palabras clave:
Tipos de documento
Novedades
Dermatología Página 1 de 1
Guías de práctica clínica |
|
Año: 2021
This guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations are for adults, young people and children aged 72 hours and over. They do not cover diagnosis.
|
|
Atopic eczema in under 12s: diagnosis and management
Año: 2021
This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.
|
|
COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
Año: 2021
The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
|
|
Año: 2020
This guideline sets out an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people and children aged 72 hours and over, including those that occurred while travelling outside the UK. It aims to limit antibiotic use and reduce antibiotic resistance.
|
|
Año: 2020
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
|
|
Año: 2019
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
|
Artículos valorados críticamente |
|
Año: 2020
Aparicio Rodrigo M, Albi Rodríguez MS. Evid Pediatr. 2020;16:19
Artículo original: Chan S, Cornelius V, Cro S, Harper JI, Lack G. Treatment effect of Omalizumab on severe pediatric atopic dermatitis: the ADAPT randomized clinical trial. JAMA Pediatr. 2020;174:29-37.
|
|
Año: 2019
Ortega Páez E, Llerena Santa Cruz E. Evid Pediatr. 2019;15:1 Artículo original: Wojcik KY, Escobedo LA, Wysong A, Heck JE, Ritz B, Hamilton AS, et al. High birth weight, early UV exposure, and melanoma risk in children, adolescents, and young adults. Epidemiology. 2019;30: 278-284. |
|
Año: 2019
Molina Arias M, Rivero Martín MJ. Evid Pediatr. 2019;15:3 Artículo original: Wickens K, Barthow C, Mitchell EA, Kang J, van Zyl N, Purdie G, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29:808-814. |
Otros |
|
|
Página 1 de 1, mostrando 10 de un total de 10